Core Viewpoint - Hendi Pharmaceutical (301211.SZ) experienced a midday decline of 5.35%, closing at 14.67 yuan, with a total market capitalization of 6.126 billion yuan due to shareholder reduction plans [1] Shareholder Reduction Plans - Three shareholders of Hendi Pharmaceutical plan to collectively reduce their holdings by no more than 2.33% of the company's shares [1] - Shareholder Ningkang Qichuan intends to reduce holdings by up to 4.176 million shares (1% of total share capital) [1] - Shareholder Beikang Qichuan plans to reduce holdings by up to 1.392 million shares (0.33% of total share capital) [1] - Shareholder Lei Xiaoyan also plans to reduce holdings by up to 4.176 million shares (1% of total share capital) [1] - The reduction will be executed through block trading or centralized bidding, with the reason cited as personal financial planning by the shareholders [1]
A股异动丨亨迪药业午间收跌5.35% 三名股东拟“组团”减持